The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study
Open accessAbstract
OBJECTIVES: To assess the risk of clinical complications associated with thrombophilia in three high-risk patient groups: women using oral oestrogen preparations, women during pregnancy and patients undergoing major orthopaedic surgery. To assess the effectiveness of prophylactic treatments in preventing venous thromboembolism (VTE) and adverse pregnancy outcomes in women with thrombophilia during pregnancy and VTE in patients with thrombophilia, undergoing major orthopaedic surgery. To evaluate the relative cost-effectiveness of universal and selective VTE history-based screening for thrombophilia compared with no screening in the three high-risk patient groups. DATA SOURCES: Electronic databases including MEDLINE, EMBASE, and four other major databases were searched up to June 2003. REVIEW METHODS: In order to assess the risk of clinical complications associated with thrombophilia, a systematic review of the literature on VTE and thrombophilia in women using oral oestrogen preparations and patients undergoing major orthopaedic surgery; and studies of VTE and adverse obstetric complications in women with thrombophilia during pregnancy was carried out. Meta-analysis was used to calculate pooled odds ratios (ORs) associated with individual clinical outcomes, stratified by thrombophilia type and were calculated for each patient group. To assess the effectiveness of prophylaxis, a systematic review was carried out on the use of prophylaxis in the prevention of VTE and pregnancy loss in pregnant women with thrombophilic defects and the use of thromboprophylaxis in the prevention of VTE in patients with thrombophilia undergoing major elective orthopaedic surgery. Relevant data were summarised according to the patient groups and stratified according to the types of prophylaxis. A narrative summary was provided; where appropriate, meta-analysis was conducted. An incremental cost-effectiveness analysis was then carried out, from the perspective of the NHS in the UK. A decision analytical model was developed to simulate the clinical consequences of four thrombophilia screening scenarios. Results from the meta-analyses, information from the literature and results of two Delphi studies of clinical management of VTE and adverse pregnancy complications were incorporated into the model. Only direct health service costs were measured and unit costs for all healthcare resources used were obtained from routinely collected data and the literature. Cost-effectiveness was expressed as incremental cost-effectiveness ratios (ICERs); an estimate of the cost per adverse clinical complication prevented, comparing screening with no screening, were calculated for each patient group. RESULTS: In the review of risk of clinical complications, 81 studies were included, nine for oral oestrogen preparations, 72 for pregnancy and eight for orthopaedic surgery. For oral contraceptive use, significant associations of the risk of VTE were found in women with factor V Leiden (FVL); deficiencies of antithrombin, protein C, or protein S, elevated levels of factor VIIIc; and FVL and prothrombin G20210A. For hormone replacement therapy (HRT), a significant association was found in women with FVL. The highest risk in pregnancy was found for FVL and VTE, in particular, homozygous carriers of this mutation are 34 times more likely to develop VTE in pregnancy than non-carriers. Significant risks for individual thrombophilic defects were also established for early, recurrent and late pregnancy loss; preeclampsia; placental abruption; and intrauterine growth restriction. Significant associations were found between FVL and high factor VIIIc and postoperative VTE following elective hip or knee replacement surgery. Prothrombin G20210A was significantly associated with postoperative pulmonary embolism. However, antithrombin deficiency, MTHFR and hyperhomocysteinaemia were not associated with increased risk of postoperative VTE. In the review of the effectiveness of prophylaxis, based on available data from eight studies, low-dose aspirin and heparin was found to be the most effective in preventing pregnancy loss in thrombophilic women during pregnancy, while aspirin alone was the most effective in preventing minor bleeding. All the studies on thrombophilia and major elective orthopaedic surgery included in the review of risk complications were also used in the review of the effectiveness of thromboprophylaxis. However, there were insufficient data to determine the relative effectiveness of different thromboprophylaxis in preventing VTE in this patient group. For the cost-effectiveness analysis, of all the patient groups evaluated, universal screening of women prior to prescribing HRT was the most cost-effective (ICER pound6824). In contrast, universal screening of women prior to prescribing combined oral contraceptives was the least cost-effective strategy (ICER pound202,402). Selective thrombophilia screening based on previous personal and/or family history
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Venous thrombosis: a multicausal disease
Rosendaal, F. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10266-0 · Cited by 1,576
The Scottish Intercollegiate Guidelines Network (SIGN)
Miller, J. (2002) · The British Journal of Diabetes & Vascular Disease · doi:10.1177/14746514020020010401 · Cited by 1,544
Egger, M., Jüni, P., Bartlett, C., Holenstein, F., & Sterne, J. (2003) · Health Technology Assessment · doi:10.3310/hta7010 · Cited by 1,181
Koster, T., Vandenbroucke, J. P., Rosendaal, F. R., Briët, E., Rosendaal, F. R., & Blann, A. D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90166-3 · Cited by 1,131
Rai, R., Cohen, H., Dave, M., & Regan, L. (1997) · BMJ · doi:10.1136/bmj.314.7076.253 · Cited by 1,113
Self-citationVandenbroucke, J. P., Koster, T., Rosendaal, F. R., Briët, E., Reitsma, P. H., & Bertina, R. M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90286-0 · Cited by 1,063
Increased Frequency of Genetic Thrombophilia in Women with Complications of Pregnancy
Kupferminc, M. J., Eldor, A., Steinman, N., Many, A., Bar-Am, A., Jaffa, A., Fait, G., & Lessing, J. B. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400102 · Cited by 956
Thrombophilic disorders and fetal loss: a meta-analysis
Rey, E., Kahn, S. R., David, M., & Shrier, I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12771-7 · Cited by 872
Increased frequency of genetic thrombophilia in women with complications of pregnancy
(1999) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(99)80075-3 · Cited by 832
Kutteh, W. H. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70610-5 · Cited by 803
Scarabin, P.-Y., Oger, E., & Plu-Bureau, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14066-4 · Cited by 714
Geographic Distribution of the 20210 G to A Prothrombin Variant
Doggen, C. J. M., Zivelin, A., Arruda, V. R., Aiach, M., Siscovick, D. S., Hillarp, A., Watzke, H. H., Bernardi, F., Cumming, A. M., Preston, F. E., et al. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615049 · Cited by 696
Bloemenkamp, K. W. M., Helmerhorst, F. M., Rosendaal, F. R., Vandenbroucke, J. P., & Büller, H. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91929-5 · Cited by 580
Absence of Thrombosis in Subjects with Heterozygous Protein C Deficiency
Miletich, J., Sherman, L., & Broze, G. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710153171604 · Cited by 524
Gerhardt, A., Scharf, R. E., Beckmann, M. W., Struve, S., Bender, H. G., Pillny, M., Sandmann, W., & Zotz, R. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420602 · Cited by 491
Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment
Farquharson, R. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02165-8 · Cited by 427
Gris, J.-C., Mercier, E., Quéré, I., Lavigne-Lissalde, G., Cochery-Nouvellon, E., Hoffet, M., Ripart-Neveu, S., Tailland, M.-L., Dauzat, M., & Marès, P. (2004) · Blood · doi:10.1182/blood-2003-12-4250 · Cited by 397
Safety of Withholding Heparin in Pregnant Women with a History of Venous Thromboembolism
Brill-Edwards, P., Ginsberg, J. S., Gent, M., Hirsh, J., Burrows, R., Kearon, C., Geerts, W., Kovacs, M., Weitz, J. I., Robinson, K. S., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432002 · Cited by 388
Activated Protein C Sensitivity, Protein C, Protein S and Coagulation in Normal Pregnancy
Brennand, J., Conkie, J. A., McCall, F., Greer, I. A., Walker, I., & Clark, P. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615035 · Cited by 386
Self-citationPrevalence of antithrombin deficiency in the healthy population
Tait, R. C., Walker, I. D., Perry, D. J., Islam, S. I. A. M., Daly, M. E., McCall, F., Conkie, J. A., & Carrell, R. W. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb04878.x · Cited by 381
Self-citationHow strong is the association between maternal thrombophilia and adverse pregnancy outcome?
Alfirevic, Z., Roberts, D., & Martlew, V. (2002) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(01)00496-1 · Cited by 339
Prevalence of Protein C Deficiency in the Healthy Population
Tait, R. C., Walker, I. D., Reitsma, P. H., Islam, S. I. A. M., McCall, F., Poort, S. R., Conkie, J. A., & Bertina, R. M. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1653730 · Cited by 336
Self-citationEmmerich, J., Rosendaal, F. R., Cattaneo, M., Margaglione, M., Stefano, V. D., Cumming, T., Arruda, V. R., Hillarp, A., & Reny, J. (2001) · PubMed · Cited by 325
Placental abruption and perinatal mortality in the United States
Ananth, C. V., & Wilcox, A. J. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.4.332 · Cited by 311
Mutations in Coagulation Factors in Women with Unexplained Late Fetal Loss
Martinelli, I., Taioli, E., Cetin, I., Marinoni, A., Gerosa, S., Villa, M. V., Bozzo, M., & Mannucci, P. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010053431405 · Cited by 304
Pattison, N. S., Chamley, L. W., Birdsall, M., Zanderigo, A. M., Liddell, H. S., & McDougall, J. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.106754 · Cited by 291
Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss
Wouters, M. G. A. J., Boers, G. H. J., Blom, H. J., Trijbels, F. J. M., Thomas, C. M. G., Borm, G. F., Steegers-Theunissen, R. P. M., & Eskes, T. K. A. B. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56282-7 · Cited by 282
The factor V Leiden mutation may predispose women to severe preeclampsia
Dizon-Townson, D. S., Nelson, L. M., Easton, K., & Ward, K. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)80022-6 · Cited by 271
Factor V Leiden Is Associated with Repeated and Recurrent Unexplained Fetal Losses
Grandone, E., Margaglione, M., Colaizzo, D., d'Addedda, M., Cappucci, G., Vecchione, G., Sciannamé, N., Pavone, G., & Di Minno, G. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656060 · Cited by 261
Heart and Estrogen/progestin Replacement Study (HERS)
Grady, D., Applegate, W., Bush, T., Furberg, C., Riggs, B., & Hulley, S. B. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00010-5 · Cited by 260
Nelson-Piercy, C., Letsky, E. A., & de Swiet, M. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70403-4 · Cited by 260
Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction
Dizon-Townson, D. S., Meline, L., Nelson, L. M., Varner, M., & Ward, K. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70205-9 · Cited by 256
Venous Thromboembolism According to Age: The Impact of an Aging Population
Stein, P. D., Hull, R. D., Kayali, F., Ghali, W. A., Alshab, A. K., & Olson, R. E. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.20.2260 · Cited by 254
Absence of Association of Thrombophilia Polymorphisms with Intrauterine Growth Restriction
Infante-Rivard, C., Rivard, G.-E., Yotov, W. V., Génin, E., Guiguet, M., Weinberg, C., Gauthier, R., & Feoli-Fonseca, J. C. (2002) · New England Journal of Medicine · doi:10.1056/nejm200207043470105 · Cited by 253
Prospective Studies of the Association Between Anticardiolipin Antibody and Outcome of Pregnancy
YASUDA, M. (1995) · Obstetrics & Gynecology · doi:10.1016/0029-7844(95)00247-o · Cited by 245
Thrombophilic Polymorphisms Are Common in Women with Fetal Loss without Apparent Cause
Sarig, G., Weiner, Z., Younis, J., Blumenfeld, Z., Lanir, N., & Brenner, B. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614620 · Cited by 244
Hyperhomocysteinemia: a risk factor for placental abruption or infarction
Goddijn-Wessel, T. A. W., Wouters, M. G. A. J., v.d. Molen, E. F., Spuijbroek, M. D. E. H., Steegers-Theunissen, R. P. M., Blom, H. J., Boers, G. H. J., & Eskes, T. K. A. B. (1996) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0301-2115(96)02383-4 · Cited by 233
High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia
van Pampus, M. G., Dekker, G. A., Wolf, H., Huijgens, P. C., Koopman, M. M. W., von Blomberg, B. M. E., & Büller, H. R. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70608-3 · Cited by 227
Factor V Leiden, C>T MTHFR Polymorphism and Genetic Susceptibility to Preeclampsia
Grandone, E., Margaglione, M., Colaizzo, D., Cappucci, G., Paladini, D., Martinelli, P., Montanaro, S., Pavone, G., & Minno, G. D. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656110 · Cited by 217
Bloemenkamp, K. W. M., Rosendaal, F. R., Helmerhorst, F. M., & Vandenbroucke, J. P. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.1.49 · Cited by 213
Foka, Z. J. (2000) · Human Reproduction · doi:10.1093/humrep/15.2.458 · Cited by 210
Sarig, G., Younis, J. S., Hoffman, R., Lanir, N., Blumenfeld, Z., & Brenner, B. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02971-5 · Cited by 209
Gris, J., Quéré, I., Monpeyroux, F., Mercier, É., Ripart-Neveu, S., Tailland, M.-L., Hoffet, M., Berlan, J., Daurès, J., & Marès, P. (1999) · PubMed · Cited by 207
Factor V Leiden Mutation as a Risk Factor for Recurrent Pregnancy Loss
Ridker, P. M., Miletich, J. P., Buring, J. E., Ariyo, A. A., Price, D. T., Manson, J. E., & Hill, J. A. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_1-199806150-00007 · Cited by 205
Lupus Anticoagulants, Anticardiolipin Antibodies, and Fetal Loss: A Case–Control Study
Infante-Rivard, C., David, M., Gauthier, R., & Rivard, G.-E. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110103251503 · Cited by 205
Middeldorp, S., Henkens, C. M. A., Koopman, M. M. W., van Pampus, E. C. M., Hamulyak, K., van der Meer, J., Prins, M. H., & Buller, H. R. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-1-199801010-00003 · Cited by 202
Inherited Thrombophilia and First Venous Thromboembolism during Pregnancy and Puerperium
De Stefano, V., Taioli, E., Paciaroni, K., Rossi, E., Pier, M., & Martinelli, I. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613085 · Cited by 201
Middeldorp, S., Meinardi, J. R., Koopman, M. M. W., van Pampus, E. C. M., Hamulyák, K., van der Meer, J., Prins, M. H., & Büller, H. R. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-5-200109040-00008 · Cited by 197
Factor V Leiden and the Risk for Venous Thromboembolism in the Adult Danish Population
Juul, K., Tybjærg-Hansen, A., Schnohr, P., & Nordestgaard, B. G. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00008 · Cited by 195
Estrogens, progestogens and thrombosis
Rosendaal, F. R., Van Hylckama Vlieg, A., Tanis, B. C., & Helmerhorst, F. M. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00264.x · Cited by 188
Morrison, E. R., Campbell, D. M., Haites, N. E., Wilson, B. J., Watson, M. S., Greaves, M., Vickers, M. A., & Miedzybrodzka, Z. H. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613083 · Cited by 185
Self-citationSevere preeclampsia and high frequency of genetic thrombophilic mutations
Kupferminc, M. (2000) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(00)00861-9 · Cited by 179
Rai, R., Shlebak, A., Cohen, H., Backos, M., Holmes, Z., Marriott, K., & Regan, L. (2001) · Human Reproduction · doi:10.1093/humrep/16.5.961 · Cited by 176
Self-citationMartinelli, I., Taioli, E., Bucciarelli, P., Akhavan, S., & Mannucci, P. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.700 · Cited by 172
Haverkate, F., Thompson, S., Turner, R., Bertina, R., Turpie, A., Mannucci, P., Lowe, G., & on behalf of the ECAT DVT Study Group (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614592 · Cited by 166
Self-citationGrandone, E., Margaglione, M., Colaizzo, D., D’Andrea, G., Cappucci, G., Brancaccio, V., & Di Minno, G. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70155-3 · Cited by 164
Kutteh, W. H., Park, V. M., & Deitcher, S. R. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00133-8 · Cited by 160
Kemmeren, J. M., Algra, A., Meijers, J. C. M., Tans, G., Bouma, B. N., Curvers, J., Rosing, J., & Grobbee, D. E. (2004) · Blood · doi:10.1182/blood-2003-04-1285 · Cited by 157
Franco, R. F., Araújo, A. G. D. M., Guerreiro, J. F., Élion, J., & Zago, M. A. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614230 · Cited by 155
Increased Risk for Fetal Loss in Carriers of the Factor V Leiden Mutation
Meinardi, J. R., Middeldorp, S., de Kam, P. J., Koopman, M. M. W., Pampus, E. C. M. V., Hamulyák, K., Prins, M. H., Buller, H. R., & van der Meer, J. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-9-199905040-00013 · Cited by 155
Murphy, R. P., Donoghue, C., Nallen, R., D’Mello, M., Regan, C. L., Whitehead, A. S., & Fitzgerald, D. J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.1.266 · Cited by 153
Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis
Rosendaal, F. R., Vessey, M. P., Rumley, A., Daly, E., Woodward, M., Helmerhorst, F. M., & Lowe, G. D. O. (2002) · British Journal of Haematology · doi:10.1046/j.0007-1048.2002.03356.x · Cited by 152
Self-citationKutteh, W. H., & Ermel, L. D. (1996) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1996.tb00501.x · Cited by 151
Herrington, D. M., Vittinghoff, E., Howard, T. D., Major, D. A., Owen, J. D., Reboussin, D. M., Bowden, D. W., Bittner, V., Simon, J. A., Grady, D. G., et al. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000018301.91721.94 · Cited by 151
Woodward, M., Vessey, M., Rumley, A., Gough, P., Daly, E., & Lowe, G. D. O. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613857 · Cited by 148
Self-citationLivingston, J., Barton, J. R., Park, V., Haddad, B., Phillips, O. P., & Sibai, B. M. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.114691 · Cited by 148
Pihusch, R., Hiller, E., Buchholz, T., Rogenhofer, N., Hasbargen, U., Thaler, C., Lohse, P., & Rübsamen, H. (2001) · American Journal of Reproductive Immunology · doi:10.1111/j.8755-8920.2001.460202.x · Cited by 148
Upton, M. N., Rumley, A., McConnachie, A., O’Reilly, D., Watt, G. C. M., & Lowe, G. D. O. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616085 · Cited by 141
Self-citationWirth, T., Schneider, B., Misselwitz, F., Lomb, M., Tüylü, H., Egbring, R., & GRISS, P. (2001) · Arthroscopy The Journal of Arthroscopic and Related Surgery · doi:10.1053/jars.2001.21247 · Cited by 139
Kupferminc, M. J., Peri, H., Zwang, E., Yaron, Y., Wolman, I., & Eldor, A. (2000) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2000.079011963.x · Cited by 139
Risk of Pregnancy-related Venous Thrombosis in Carriers of Severe Inherited Thrombophilia
Legnani, C., Bucciarelli, P., Grandone, E., Stefano, V. D., Mannucci, P. M., & Martinelli, I. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616134 · Cited by 136
Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss
Carp, H., Salomon, O., Seidman, D. S., Dardik, R., Rosenberg, N., & Inbal, A. (2002) · Human Reproduction · doi:10.1093/humrep/17.6.1633 · Cited by 135
Krnic-Barrie, S. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440390101013 · Cited by 134
Preeclampsia and genetic risk factors for thrombosis: A case-control study
de Groot, C. J. M., Bloemenkamp, K. W. M., Duvekot, E. J., Helmerhorst, F. M., Bertina, R. M., b, F. V. D. M., b, H. D. R., Oei, S. G., Kanhai, H. H. H., & Rosendaal, F. R. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70335-2 · Cited by 132
Pabinger, I., & Schneider, B. (1994) · PubMed · Cited by 129
Postnatal screening for thrombophilia in women with severe pregnancy complications*1
Alfirević, Ž. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01190-5 · Cited by 128
Younis, J. S., Ben‐Ami, M., BRENNER, B., Ohel, G., & Tal, J. (2000) · American Journal of Reproductive Immunology · doi:10.1111/j.8755-8920.2000.430106.x · Cited by 127
Thrombophilia: implications for pregnancy outcome
Greer, I. A. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00095-1 · Cited by 126
Self-citationFinan, R. R., Tamim, H., Ameen, G., Sharida, H. E., Rashid, M., & Almawi, W. Y. (2002) · American Journal of Hematology · doi:10.1002/ajh.10223 · Cited by 119
O’Shaughnessy, K. M., Fu, B., Ferraro, F., et al. (1999) · Hypertension · doi:10.1161/01.hyp.33.6.1338 · Cited by 116
Factor V Leiden paradox: risk of deepvein thrombosis but not of pulmonary embolism
Bounameaux, H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02476-4 · Cited by 116
Samama, M. M., Dahl, O. E., Quinlan, D. J., Mismetti, P., & Rosencher, N. (2003) · PubMed · Cited by 116
Raziel, A., Friedler, S., SCHACHTER, M., Ron-El, R., KORNBERG, Y., & Sela, B.-A. (2001) · American Journal of Reproductive Immunology · doi:10.1111/j.8755-8920.2001.450201.x · Cited by 112
Third-Trimester Unexplained Intrauterine Fetal Death Is Associated With Inherited Thrombophilia
Many, A., Elad, R., Yaron, Y., Eldor, A., Lessing, J. B., & Kupferminc, M. J. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)01938-5 · Cited by 112
Qvigstad, E., Andersen, T. O., Mowinckel, M.-C., Sandset, P. M., & Høibraaten, E. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615717 · Cited by 109
Familial thrombophilia and the occurrence of fetal growth restriction.
Martinelli, P., Grandone, E., Colaizzo, D., Paladini, D., Sciannamè, N., Margaglione, M., & Minno, G. D. (2001) · PubMed · Cited by 108
Antiphospholipid antibodies in women at risk for preeclampsia
Branch, D. W., Porter, T. F., Rittenhouse, L., Caritis, S. N., Sibai, B. M., Hogg, B. B., Lindheimer, M. D., Klebanoff, M. A., MacPherson, C., VanDorsten, J. P., et al. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.113846 · Cited by 107
Wiener‐Megnazi, Z., Ben‐Shlomo, I., Goldberg, Y., & Shalev, E. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70025-0 · Cited by 104
Antiphospholipid antibodies and recurrent abortion.
Parazzini, F., Acaia, B., Faden, D., Lovotti, M., Marelli, G., & Cortelazzo, S. (1991) · PubMed · Cited by 102
Thrombophilia in pregnancy: Table 1
Walker, I. D. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.8.573 · Cited by 102
Self-citationThe factor V Leiden mutation is not a common cause of recurrent miscarriage
Dizon‐Townson, D., Kinney, S., Branch, D. W., & Ward, K. J. (1997) · Journal of Reproductive Immunology · doi:10.1016/s0165-0378(97)00039-9 · Cited by 100
Rigó, J., Rigó, J. J., Nagy, B., Fintor, L., Tanyi, J., Beke, A., Karádi, I., & Papp, Z. (2000) · Hypertension in Pregnancy · doi:10.1081/prg-100100132 · Cited by 100
Acquired and inherited thrombophilia in women with unexplained fetal losses
Alonso, A., Soto, I., Urgellés, M. F., Corte, J. R., Rodriguez, M. J., & Pinto, C. R. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.126849 · Cited by 97
Reznikoff‐Etiévant, M. F., Cayol, V., Carbonne, B., Robert, A., Coulet, F., & Milliez, J. M. (2001) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2001.00298.x · Cited by 95
Franklin, R. D., & Kutteh, W. H. (2002) · Human Reproduction · doi:10.1093/humrep/17.11.2981 · Cited by 92
Tal, J., Schliamser, L., Leibovitz, Z., Ohel, G., & Atias, D. (1999) · Human Reproduction · doi:10.1093/humrep/14.6.1624 · Cited by 89
Causes Of Intrauterine Growth Restriction
Neerhof, M. G. (1995) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30289-6 · Cited by 87
Recurrent stillbirth. Significance and characteristics.
Samueloff, A., Xenakis, E. M.-J., Berkus, M. D., Huff, R. W., & Langer, O. (1993) · PubMed · Cited by 87
Kupferminc, M. J., Many, A., Bar‐Am, A., Lessing, J. B., & Ascher-Landsberg, J. (2002) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1016/s1470-0328(02)02994-4 · Cited by 87
First-trimester repeated abortion is not associated with activated protein C resistance
Balasch, J., Reverter, J. C., Fábregues, F., Tàssies, D., Rafel, M., Creus, M. T., & Vanrell, J. A. (1997) · Human Reproduction · doi:10.1093/humrep/12.5.1094 · Cited by 85
Aznar, J. A., Vayá, A., Estellés, A., et al. (2000) · PubMed · Cited by 85
Activated Protein C Resistance and the FV:R506Q Mutation in a Random Population Sample
Rumley, A., Woodward, M., Reid, E., Rumley, J., & Lowe, G. D. O. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614599 · Cited by 83
Self-citationLensen, R., Rosendaal, F. R., Koster, T., Allaart, C. F., de Ronde, H., Vandenbroucke, J. P., Reitsma, P. H., & Bertina, R. M. (1996) · Blood · doi:10.1182/blood.v88.11.4205.4205 · Cited by 82
Mansvelt, E. P. G., Laffan, M., McVey, J. H., & Tuddenham, E. G. D. (1998) · PubMed · Cited by 77
Margaglione, M., Colaizzo, D., Cappucci, G., Sciannamè, N., Montanaro, S., Paladini, D., Martinelli, P., Minno, G. D., & Grandone, E. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614475 · Cited by 76
Detection of factor V Leiden mutation in severe pre‐eclamptic Hungarian women
Nagy, B., Tóth, T., Rigó, J. J., et al. (1998) · Clinical Genetics · doi:10.1111/j.1399-0004.1998.tb02599.x · Cited by 76
Fatini, C., Gensini, F., Battaglini, B., Prisco, D., Cellai, A. P., Fedi, S., Marcucci, R., Brunelli, T., Mello, G., Parretti, E., et al. (2000) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200010000-00010 · Cited by 76
Ogasawara, M., Aoki, K., Matsuura, E., Sasa, H., & Yagami, Y. (1996) · Lupus · doi:10.1177/096120339600500605 · Cited by 75
The Estrogen Replacement and Atherosclerosis (ERA) Study
Herrington, D. M., Reboussin, D. M., Klein, K. P., Sharp, P. C., Shumaker, S. A., Snyder, T. E., & Geisinger, K. R. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00054-4 · Cited by 74
Lundahl, T., Nilsson, L. E., Andersson, C., et al. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614410 · Cited by 74
Ryan, D. H., Crowther, M. A., Ginsberg, J. S., & Francis, C. W. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-4-199802150-00003 · Cited by 73
Venous thromboembolism in young women. Role of thrombophilic mutations and oral contraceptive use
Legnani, C., Palareti, G., Guazzaloca, G., Cosmi, B., Lunghi, B., Bernardi, F., & Coccheri, S. (2002) · European Heart Journal · doi:10.1053/euhj.2001.3082 · Cited by 73
Lissak, A., Sharon, A., Fruchter, O., Kassel, A., Sanderovitz, J., & Abramovici, H. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70447-3 · Cited by 69
Antiphospholipid antibodies and preeclampsia: a case-control study
Dreyfus, M., Hedelin, G., Kutnahorsky, R., Lehmann, M., Viville, B., Langer, B., Fleury, A., M'Barek, M., Treisser, A., Wiesel, M. L., et al. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(00)01099-1 · Cited by 69
Screening for factor V leiden mutation before prescribing combination oral contraceptives
Creinin, M. D., Lisman, R., & Strickler, R. C. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00318-0 · Cited by 68
Venous Thrombosis, Oral Contraceptives and High Factor VIII Levels
Bloemenkamp, K. W. M., Helmerhorst, F., Vandenbroucke, J. P., & Rosendaal, F. R. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614323 · Cited by 68
Pabinger, I., Nemes, L., Rintelen, C., Koder, S., Lechler, E., Loreth, R. M., Kyrle, P. A., Scharrer, I., Sas, G., Lechner, K., et al. (2000) · The Hematology Journal · doi:10.1038/sj.thj.6200005 · Cited by 67
The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss
Holmes, Z. R., Regan, L., Chilcott, I., & Cohen, H. (1999) · British Journal of Haematology · doi:10.1111/j.1365-2141.1999.01319.x · Cited by 64
Self-citationDulitzki, M., Langevitz, P., Livneh, A., Kenett, R., Many, A., & Pauzner, R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616739 · Cited by 63
Rintelen, C., Mannhalter, C., Ireland, H., Lane, D. A., Knöbl, P., Lechner, K., & Pabinger, I. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.5712013.x · Cited by 62
D'Elia, A. V., Driul, L., Giacomello, R., Colaone, R., Fabbro, D., Leonardo, C. D., Florio, P., Petraglia, F., Marchesoni, D., & Damante, G. (2002) · Gynecologic and Obstetric Investigation · doi:10.1159/000052998 · Cited by 61
Andersen, B. S., Olsen, J., Nielsen, G. L., Steffensen, F. H., Sørensen, H. T., Bæch, J., & Gregersen, H. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614213 · Cited by 57
The Risk of Fetal Loss in Family Members of Probands with Factor V Leiden Mutation
Tormene, D., Simioni, P., Luni, S., et al. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614367 · Cited by 57
Cosmi, B., Legnani, C., Bernardi, F., COCCHERI, S., & Palareti, G. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1105 · Cited by 56
Laboratory testing for heritable thrombophilia: impact on clinical management of thrombotic disease
Greaves, M., & Baglin, T. P. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02185.x · Cited by 54
Self-citationFactor V Leiden: the venous thrombotic risk in thrombophilic families
Lensen, R., Rosendaal, F. R., Vandenbroucke, J. P., & Bertina, R. M. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02236.x · Cited by 54
Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.
Tormene, D., Simioni, P., Prandoni, P., Luni, S., Zerbinati, P., Sartor, D., Franz, F., & Girolami, A. (2001) · PubMed · Cited by 53
Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome
Αγοραστός, Θ., Karavida, A., Lambropoulos, A. F., Constantinidis, T. C., Tzitzimikas, S., Chrisafi, S., Saravelos, H., Vavilis, D., Kotsis, A., & Bontis, J. N. (2002) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/jmf.12.4.267.273 · Cited by 52
Schambeck, C. M., Schwender, S., Haubitz, I., Geisen, U., Großmann, R., & Keller, F. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1665437 · Cited by 49
Mello, G., Parretti, E., Martini, E., et al. (1999) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022502 · Cited by 45
Factor V Leiden as a risk factor for miscarriage and reduced fertility
Baré, S., Póka, R., Balogh, I., et al. (2000) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2000.tb01144.x · Cited by 45
G20210A Prothrombin Gene Mutation: Prevalence in a Recurrent Miscarriage Population
Pickering, W., Marriott, K., & Regan, L. (2001) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602960100700106 · Cited by 44
Self-citationJackson, A., Brown, K., Langdown, J., Luddington, R. J., & Baglin, T. P. (2000) · British Journal of Haematology · doi:10.1111/j.1365-2141.2000.02408.x · Cited by 43
Birth outcomes in pregnant women treated with low-molecular-weight heparin
Sørensen, H. T., Johnsen, S. P., LARSEN, H., Pedersen, L. H., Nielsen, G. L., & Møller, M. (2000) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2000.079008655.x · Cited by 42
Management of venous thromboembolism in pregnancy
Greer, I. A., & Thomson, A. J. (2001) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1053/beog.2001.0202 · Cited by 42
Self-citationNelen, W. L. D. M., van der Molen, E. F., Blom, H. J., et al. (1999) · PubMed · Cited by 42
Mutations in the factor V, prothrombin and MTHFR genes are not risk factors for recurrent fetal loss
Dilley, A., Benito, C. W., Hooper, W. C., Austin, H. D., Miller, C. H., El-Jamil, M., Cottrell, S., Benson, J. M., Evatt, B. L., Patterson-Barnett, A., et al. (2002) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/jmf.11.3.176.182 · Cited by 41
Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?
Spannagl, M., Heinemann, L. A. J., & Schramm, W. (2000) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625180008500383 · Cited by 40
Davies, L. M., Richardson, G., & Cohen, A. T. (2000) · Value in Health · doi:10.1046/j.1524-4733.2000.36005.x · Cited by 38
Hyperhomocysteinemia ‐ A risk factor for abruptio placentae
Owen, E. P., Human, L. E., Carolissen, A. A., Harley, E. H., & Odendaal, H. J. (1997) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005373810756 · Cited by 36
Eckman, M. H., Singh, S. K., Erban, J. K., & Kao, G. (2002) · Medical Decision Making · doi:10.1177/0272989x0202200209 · Cited by 36
Santamaría, A., Mateo, J., Oliver, A., et al. (2001) · PubMed · Cited by 34
Bennet, L., & Odeberg, H. (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00310.x · Cited by 30
Marchetti, M. (2001) · QJM · doi:10.1093/qjmed/94.7.365 · Cited by 30
Treatment of deep venous thrombosis with low-molecular-weight heparin during pregnancy
Ulander, V., Stenqvist, P., & Kaaja, R. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00074-9 · Cited by 30
Emmerich, J., Rosendaal, F. R., Cattaneo, M., Margaglione, M., De Stefano, V., Cumming, T., Arruda, V. R., Hillarp, A., & Reny, J. (2001) · Lund University Publications (Lund University) · Cited by 29
Screening for activated protein C resistance before oral contraceptive treatment: a pilot study
Palareti, G., Legnani, C., Frascaro, M., Flamigni, C., Gammi, L., Gola, G., Fuschini, G., & COCCHERI, S. (1999) · Contraception · doi:10.1016/s0010-7824(99)00033-5 · Cited by 26
Poor Pregnancy Outcome and Anticardiolipin Antibodies
Carolis, S. D., Caruso, A., Ferrazzani, S., Carducci, B., Santis, L. D., & Mancuso, S. (2009) · Fetal Diagnosis and Therapy · doi:10.1159/000263951 · Cited by 26
(1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(96)89713-x · Cited by 24
Hatzis, T., Cardamakis, E., Drivalas, E., et al. (1999) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625189909040808 · Cited by 22
Prophylaxis for Venous Thromboembolism
Ma, K., Alhassan, S., Sharara, R. S., Young, M., Singh, A. C., & Bihler, E. (2017) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000161 · Cited by 20
Boda, Z., László, P., Rejtő, L., Tornai, I., Pfliegler, G., Blaskó, G., & Rák, K. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650538 · Cited by 19
Postnatal Screening for Thrombophilia in Women With Severe Pregnancy Complications
Alfirević, Ž., Mousa, H., Martlew, V., Briscoe, L., Pérez‐Casal, M., & Toh, C. (2001) · Obstetrics and Gynecology · doi:10.1097/00006250-200105000-00021 · Cited by 19
Higashino, M., Takakuwa, K., Arakawa, M., Tamura, M., Yasuda, M., & Tanaka, K. (1998) · Journal of Perinatal Medicine · doi:10.1515/jpme.1998.26.5.384 · Cited by 18
Pini, M., Scoditti, U., Caliumi, F., et al. (1996) · PubMed · Cited by 16
Oral Contraception and Factor V Leiden Mutation in Relation to Localization of Deep Vein Thrombosis
Andersen, B. S., & Olsen, J. (1998) · Thrombosis Research · doi:10.1016/s0049-3848(98)00028-0 · Cited by 15
Study of Lupus Anticoagulant in Pregnant Women with Recurrent Abortion
Das, I., Vasishta, K., & Dash, S. (1991) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.1991.tb02812.x · Cited by 14
Cohen, H. (1996) · PubMed · Cited by 13
Thrombophilia and lipid profile in post-menopausal women using a new transdermal oestradiol patch
Habiba, M. A., Akkad, A., Phipps, B., & Al‐Azzawi, F. (1996) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0301-2115(96)02400-1 · Cited by 11
Mira, Y., Aznar, J., Estellés, A., Vayá, A., Villa, P., & Ferrando, F. (2000) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602960000600308 · Cited by 10
Preeclampsia and Fetal Growth Retardation: Is There an Association with Antiphospholipid Antibodies?
Schjetlein, R., Haugen, G. N., Moe, N., Husby, H., & Wislöff, F. (1998) · Hypertension in Pregnancy · doi:10.3109/10641959809072240 · Cited by 7
Matrix metalloproteinases‐9 in preterm and term human parturition
Athayde, N., Romero, R. J., Gómez, R., Maymon, E., Pacora, P., Mazor, M., Yoon, B. H., Fortunato, S. J., Menon, R., Ghezzi, F., et al. (1999) · The Journal of Maternal-Fetal Medicine · doi:10.1002/(sici)1520-6661(199909/10)8:5<228::aid-mfm6>3.0.co;2-2 · Cited by 7
Kutteh, W. H. (2003) · Human Reproduction · doi:10.1093/humrep/deg194 · Cited by 5
Cited by
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases
Endorsed by: the European Stroke Organisation (ESO), Authors/Task Force Members, Tendera, M., Aboyans, V., Bartelink, M.-L., Baumgartner, I., Clément, D., Collet, J.-P., Cremonesi, A., De Carlo, M., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr211 · Cited by 1,506
Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306
Emery, P., Keystone, E., Tony, H. P., Cantagrel, A., van Vollenhoven, R., Sanchez, A., Alecock, E., Lee, J., & Kremer, J. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092932 · Cited by 1,104
Bushnell, C., McCullough, L. D., Awad, I. A., Chireau, M. V., Fedder, W. N., Furie, K. L., Howard, V. J., Lichtman, J. H., Lisabeth, L. D., Piña, I. L., et al. (2014) · Stroke · doi:10.1161/01.str.0000442009.06663.48 · Cited by 941
Metadata
- Authors
- Wu, O., Robertson, L., Twaddle, S., Lowe, G., Clark, P., Greaves, M., Walker, I., Langhorne, P., Brenkel, I., Regan, L., & Greer, I.
- Venue
- Health Technology Assessment
- Published
- 2006-04
- Volume
- 10
- Issue
- 11
- Pages
- 1-110
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2104086174
- Cited by
- 489
- References
- 166
- FWCI
- 14.17
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.